PTCHD1 inhibitors are a class of chemical compounds that modulate the activity of the Patched Domain-Containing 1 (PTCHD1) protein, which is a member of the Patched (PTCH) family. These inhibitors typically function by interfering with the normal biological activity of PTCHD1, which is known to be involved in cellular signaling pathways. PTCHD1 shares homology with other Patched proteins that are part of the Hedgehog signaling pathway, a crucial regulator of developmental processes and cellular differentiation. However, unlike PTCH1, the prototypical Patched receptor, the specific function and downstream signaling mechanisms of PTCHD1 are less understood. As inhibitors of PTCHD1, these compounds may alter the normal signaling cascades in which PTCHD1 is involved, leading to changes in cellular function and behavior. Structurally, PTCHD1 inhibitors can vary widely, but they generally possess molecular features that enable binding to the PTCHD1 protein, disrupting its normal interactions or functions.
Chemically, PTCHD1 inhibitors may belong to different classes based on their specific molecular scaffolds, binding mechanisms, and physicochemical properties. They often contain functional groups that facilitate interactions with the hydrophobic or hydrophilic domains of PTCHD1, allowing for a range of binding affinities and specificities. These inhibitors are studied for their capacity to affect cellular processes such as signal transduction, cell proliferation, and differentiation by modulating PTCHD1 activity. The inhibitors are commonly synthesized through rational design, structure-activity relationship (SAR) studies, and high-throughput screening of chemical libraries to identify potent molecules that effectively target PTCHD1. Due to the complexity of the Hedgehog pathway and PTCHD1's role within it, these inhibitors provide tools for investigating the fundamental biological role of PTCHD1 and for understanding how its modulation affects cellular processes. Their discovery and development involve a detailed understanding of PTCHD1's structure, ligand-binding characteristics, and its place within the broader family of Patched proteins.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
An inhibitor of the Hedgehog (Hh) signaling pathway which binds directly to PTCHD1, leading to its inactivation and subsequent decrease in pathway activity. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $80.00 $96.00 | 1 | |
A small molecule that antagonizes Hh signaling by binding to PTCHD1, preventing the pathway activation and thus reducing PTCHD1-mediated signaling. | ||||||
Erismodegib | 956697-53-3 | sc-396280 sc-396280A | 10 mg 100 mg | $255.00 $918.00 | ||
A selective antagonist of the Hh pathway which interacts with PTCHD1, attenuating the pathway signaling that PTCHD1 is part of. | ||||||
GANT61 | 500579-04-4 | sc-202630 sc-202630A sc-202630B | 1 mg 5 mg 10 mg | $63.00 $128.00 $200.00 | 6 | |
A molecule that targets the downstream Gli transcription factors in the Hh pathway, indirectly leading to the reduced function of PTCHD1 by inhibiting its downstream effects. | ||||||
Jervine | 469-59-0 | sc-200934 sc-200934A | 1 mg 5 mg | $66.00 $240.00 | 1 | |
An alkaloid that modulates Hh signaling through direct interaction with components of the pathway, including PTCHD1, leading to a decrease in PTCHD1 activity. | ||||||
Saridegib | 1037210-93-7 | sc-507351 | 5 mg | $3500.00 | ||
A compound that inhibits Hh signaling by directly interacting with PTCHD1, resulting in decreased functional activity of PTCHD1. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $76.00 $139.00 | 23 | |
Has been found to inhibit Hh signaling by affecting pathway components, including PTCHD1, leading to downregulation of its activity. | ||||||
Glasdegib | 1095173-27-5 | sc-507353 | 5 mg | $165.00 | ||
A molecule that inhibits the Hh pathway by binding to PTCHD1, which is essential for the pathway's activation, thus hindering PTCHD1's function. | ||||||
PF-5274857 | 1373615-35-0 | sc-478208 | 5 mg | $360.00 | ||
A molecule that inhibits Hh pathway signaling by targeting PTCHD1, leading to a reduction in PTCHD1-mediated signal transduction. | ||||||